Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

RNS - AlzChem Group AG: AlzChem creates additional capacity for growth for pharmaceutical applications

Company: AlzChem Group AG Date: 2021-06-21 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 News Details

Corporate | 21 June 2021 15:54

#   

AlzChem Group AG: AlzChem creates additional capacity for growth for pharmaceutical applications

DGAP-News: AlzChem Group AG / Key word(s): Miscellaneous  

21.06.2021 / 15:54  

The issuer is solely responsible for the content of this announcement.  

**AlzChem creates additional capacity for growth for pharmaceutical applications**

-   **Expansion of nitrile plant successfully commissioned**
-   **NITRALZ (R) product line continues to grow with applications in the pharmaceutical and agrochemical markets, as UV absorbers and environmentally friendly color pigments**

  

Trostberg, June 21, 2021 – AlzChem Group AG is ready for further growth of its nitrile business, especially with applications in the pharmaceutical and agrochemical markets. With an investment volume of around EUR 12 million and after a construction period of around 15 months, the 50% increase in production capacity was commissioned on budget and on time. Depending on the product mix, AlzChem expects this to generate additional annual sales of at least EUR 10 million to a maximum of EUR 20 million.

Andreas Niedermaier, CEO of AlzChem Group AG: “We are the only supplier of specialty nitriles outside China. This unique position is paying off more and more because many pharmaceutical manufacturers are aligning their supply chains to be more European and more secure. Especially since we commissioned a plant for the production of highly pure and corrosive dichloronitriles in 2019, our NITRALZ (R) product line has been able to prove itself as an important pillar of our growth strategy – even in the challenging year 2020. Applications in the pharmaceutical market as a starting material for important drugs for the treatment of cardiovascular diseases as well as HIV are diverse and in some cases only just beginning. Applications as a biocide, as environmentally friendly color pigments, or as an additive in sunscreens as a UV absorber are also extremely broad and growing. At the same time, from our point of view, not all possible applications have been tapped by any means. We will see even more interesting areas of application and innovations here in the future.”

AlzChem uses a highly efficient and environmentally friendly gas phase technology in nitrile production. Thanks to this special expertise, AlzChem is able to produce a broad portfolio of sophisticated nitriles. Supported by a comprehensive intra-European supply chain and reflective logistics, AlzChem has developed into a sustainable source for a wide range of nitriles in recent years – in line with the goal of contributing to greater sustainability and ecological action with NITRALZ (R) from AlzChem.  

  

  

**About AlzChem**  

AlzChem is a globally active specialty chemicals company that is one of the market leaders in its fields of activity, also in the international segment. With its broad product range, AlzChem benefits in a special way from the four very different global megatrends of energy efficiency, sustainability, healthy aging and population growth, insofar as efficiency in food production can be decisively improved. Here, AlzChem products offer attractive solutions in a wide range of different applications.

The company sees interesting growth prospects for itself in particular in the areas of human and animal nutrition, pharmaceuticals, agriculture, fine chemicals, metallurgy and renewable energies. The company’s broad product range includes dietary supplements, plant growth regulators and precursors for corona tests.

AlzChem employs around 1,630 people at four production sites in Germany and Sweden, and at two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.

  

  

  

Contact:  

Sabine Sieber  

Head of Investor Relations & Communications

  

- - -

21.06.2021 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.  

The issuer is solely responsible for the content of this announcement.  

  

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.  

Archive at www.dgap.de  

- - -

|     |     |
| --- | --- |
| Language: | English |
| Company: | AlzChem Group AG |
|     | Dr.-Albert-Frank-Str. 32 |
|     | 83308 Trostberg |
|     | Germany |
| Phone: | +498621862888 |
| Fax: | +49862186502888 |
| E-mail: | ir@alzchem.com |
| Internet: | www.alzchem.com |
| ISIN: | DE000A2YNT30 |
| WKN: | A2YNT3 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
| EQS News ID: | 1210293 |

  

|     |     |
| --- | --- |
|     |     |
| End of News | DGAP News Service |

![show this](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1210293&application_name=news&site_id=news_data)